US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Conatus Pharmaceuticals

0.5560

+0.0000

Volume:- -

Turnover:- -

Market Cap:18.44M

PE:-1.82

High:0.5560

Open:0.5560

Low:0.5560

Close:0.5560

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Conatus Pharmaceuticals

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.conatuspharma.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines for the treatment of liver diseases in the United States. Its product candidate includes Emricasan, an orally active caspase protease inhibitor that is in Phase IIb clinical trials for post-orthotopic liver transplant as a result of hepatitis C virus infection with sustained viral response; for portal hypertension; for liver fibrosis caused by nonalcoholic steatohepatitis; and for liver function. The company is also developing CTS-2090, an orally active inhibitor of caspase 1, which is in preclinical development stage for treating chronic diseases involving inflammasome pathways. The company has a collaboration agreement with Novartis to conduct three Phase IIb clinical trials. Conatus Pharmaceuticals Inc. was founded in 2005 and is headquartered in San Diego, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CNAT/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNAT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNAT\",,,,,undefined,":{"symbol":"CNAT","market":"US","secType":"STK","nameCN":"Conatus Pharmaceuticals","latestPrice":0.556,"timestamp":1590523200000,"preClose":0.556,"halted":8,"volume":0,"delay":0,"floatShares":32341078,"shares":33170487,"eps":-0.305062,"marketStatus":"Pre-Mkt","change":0,"latestTime":"04-29 04:19:58 EDT","open":0.556,"high":0.556,"low":0.556,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.305062,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745933400000},"marketStatusCode":1,"symbolChange":{"newSymbol":"HSTO","executeDate":"2020-05-27"},"adr":0,"adrRate":0,"listingDate":1374724800000,"exchange":"NASDAQ","adjPreClose":0.556,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNAT\",,,,,undefined,":{"symbol":"CNAT","floatShares":32341078,"roa":"-21.85%","roe":"-49.07%","lyrEps":-0.343242,"shares":33170487,"dividePrice":0,"high":0.556,"amplitude":0,"preClose":0.556,"low":0.556,"week52Low":0.2303,"pbRate":"1.05","week52High":1.07,"institutionHeld":0,"latestPrice":0.556,"eps":-0.305062,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.305062,"open":0.556},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.conatuspharma.com","stockEarnings":[{"period":"1week","weight":-0.9},{"period":"1month","weight":-0.9},{"period":"3month","weight":-0.9},{"period":"6month","weight":-0.9},{"period":"1year","weight":-0.9},{"period":"ytd","weight":-0.9}],"compareEarnings":[{"period":"1week","weight":0.0719},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0888},{"period":"6month","weight":-0.0503},{"period":"1year","weight":0.0838},{"period":"ytd","weight":-0.0601}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines for the treatment of liver diseases in the United States. Its product candidate includes Emricasan, an orally active caspase protease inhibitor that is in Phase IIb clinical trials for post-orthotopic liver transplant as a result of hepatitis C virus infection with sustained viral response; for portal hypertension; for liver fibrosis caused by nonalcoholic steatohepatitis; and for liver function. The company is also developing CTS-2090, an orally active inhibitor of caspase 1, which is in preclinical development stage for treating chronic diseases involving inflammasome pathways. The company has a collaboration agreement with Novartis to conduct three Phase IIb clinical trials. Conatus Pharmaceuticals Inc. was founded in 2005 and is headquartered in San Diego, California.","exchange":"NASDAQ","name":"Conatus Pharmaceuticals","nameEN":"Conatus Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CNAT\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNAT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-27","symbol":"CNAT","oldSymbol":"CNAT","newSymbol":"HSTO","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1590552000000},{"market":"US","date":"2020-05-27","symbol":"CNAT","type":"split","dateTimestamp":1590552000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2020-05-01","symbol":"CNAT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1588305600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-03-11","symbol":"CNAT","fiscalQuarterEnding":"2019/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1583899200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2019-11-05","symbol":"CNAT","fiscalQuarterEnding":"2019/09","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1572930000000,"reportTimeType":"post","actualEps":-0.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNAT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNAT\",market:\"US\",delay:false,,,undefined,":{}}}